Group 1 - The core focus of Aipeng Medical (300753) in recent days has been on the progress of its brain-computer interface business and institutional research interest [1] - The anesthesia puncture robot project is still in the design and development stage, with no significant breakthroughs reported [1] - Brain-computer interface technology has become a key focus for institutional research, highlighting advancements in EEG technology and the commercialization of cutting-edge brain state research, driven by policy support and technological breakthroughs [1] Group 2 - The stock price of Aipeng Medical has shown volatility, influenced by sentiment in the brain-computer interface sector [2] - On February 11, 2026, the stock price fell by 1.11% with a trading volume of 118 million yuan and a net outflow of main funds [2] - The stock had previously risen by 4.13% on February 6, 2026, closing at 34.57 yuan, driven by inflows related to the brain-computer interface concept [2] - As of February 12, 2026, the stock price was 33.39 yuan, reflecting a 1.37% increase from the previous day, but a cumulative decline of 3.41% over the past five days, indicating short-term market divergence [2]

Group 1 - The core viewpoint of the article highlights that the company Aipeng Medical is currently in the design and development phase of its anesthesia puncture robot project, with plans to disclose updates based on research and clinical validation progress [1] - The company has successfully obtained three registration certificates for its next-generation ADM series anesthesia depth monitoring devices, which have been launched in over 20 provinces and have started generating sales [1] - The implementation of the "Guidelines for the Review of Imported Products in Government Procurement" (2021 version) by the Ministry of Finance and the Ministry of Industry and Information Technology mandates that the procurement ratio for domestic products of "electroencephalogram anesthesia depth monitoring devices" should not be less than 50%, which will further promote the development of domestic anesthesia depth monitoring devices and create opportunities for domestic substitution [1]

Group 1 - The core viewpoint of the article is that Aipeng Medical's anesthesia puncture robot project is still in the design and development stage, with disclosures to be made based on R&D progress and clinical validation [1] - The new generation ADM series anesthesia depth monitor has obtained three registration certificates and has been listed in over 20 provinces, generating sales [1] - The implementation of the "Guidelines for the Review of Imported Products in Government Procurement" (2021 version) by the Ministry of Finance and the Ministry of Industry and Information Technology mandates that the procurement ratio of domestic products for "electroencephalogram anesthesia depth monitors" should not be less than 50%, which will further promote the development of domestic anesthesia depth monitors and create opportunities for domestic substitution [1]